Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Other Non Operating Income (2022 - 2025)

CervoMed's Other Non Operating Income history spans 7 years, with the latest figure at -$1227.0 for Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 64.33% year-over-year to -$1227.0; the TTM value through Sep 2025 reached -$8892.0, down 105.98%, while the annual FY2024 figure was -$991.0, 100.02% down from the prior year.
  • Other Non Operating Income for Q3 2025 was -$1227.0 at CervoMed, up from -$10256.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $4.8 million in Q3 2023 and bottomed at -$620059.0 in Q4 2022.
  • The 4-year median for Other Non Operating Income is -$423.5 (2023), against an average of $399077.0.
  • The largest annual shift saw Other Non Operating Income soared 554.33% in 2024 before it tumbled 4052.23% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at -$620059.0 in 2022, then surged by 99.9% to -$600.0 in 2023, then skyrocketed by 554.33% to $2726.0 in 2024, then tumbled by 145.01% to -$1227.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Other Non Operating Income are -$1227.0 (Q3 2025), -$10256.0 (Q2 2025), and -$135.0 (Q1 2025).